Key Market Indicators
South Africa's vaccination coverage for children aged one is projected to remain stagnant at 76% by 2028, unchanged from the current 76% in 2023. This consistency reflects a flat compound annual growth rate (CAGR), despite a historical year-on-year increase of 0.5 percentage points since 1988. In contrast, South Africa's vaccine imports are expected to surge, reaching approximately $182 million by 2028, up from around $164 million in 2023. This represents a steady 1.5% annual growth rate. Since 2005, the country's demand for vaccines has increased by an average of 3.8% per year. On the export front, South Africa's vaccine shipments are forecasted to grow modestly to nearly $3.84 million by 2028, from about $3.64 million in 2023, marking an average annual growth rate of 0.7%. Historical data since 2005 shows a year-on-year supply increase of 0.8%. In the global ranking, South Africa held the 36th position in vaccine exports in 2023, with Lithuania surpassing it at $3.64 million. Leading the rankings were Belgium, the United Kingdom, and France, occupying the 2nd, 3rd, and 4th spots, respectively.
